Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Thursday, September 28, 2023
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
Bayer extends Partnership with Peking University to foster Pharmaceutical Innovation in China
admin
-
July 14, 2023
Latest Pharma-News
FDA Approves First Nonprescription Daily Oral Contraceptive
admin
-
July 14, 2023
Latest Pharma-News
Enhertu approved in China for patients with HER2-low metastatic breast cancer
admin
-
July 14, 2023
Latest Pharma-News
FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer’s Disease
admin
-
May 17, 2023
Latest Pharma-News
FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause
admin
-
May 17, 2023
Latest Pharma-News
Collaboration of Bayer and Pharmaron to develop new molecular entities for veterinary medicines
admin
-
November 30, 2019
0
Latest Pharma-News
QIAGEN and DiaSorin receive FDA approval for the LIAISON QuantiFERON-TB Plus Test the fourth-generation modern gold standard for latent tuberculosis (TB) detection, on DiaSorin’s...
admin
-
November 29, 2019
0
Latest Pharma-News
NICE approves Ibrance via Cancer Drugs Fund in combination with fulvestrant for the treatment of women who have hormone receptor positive (HR+) and HER2-...
admin
-
November 29, 2019
0
Latest Pharma-News
Elsevier acquires 3D4Medical, initiator of world-leading 3D anatomy technology and design
admin
-
November 29, 2019
0
Latest Pharma-News
USFDA Approves Biocon and Mylan’s supplemental Biologics License Application (sBLA) for Pegfilgrastim Drug Substance to be manufactured at Biocon’s new Biologics manufacturing facility
admin
-
November 28, 2019
0
Latest Pharma-News
The U.S. Food and Drug Administration orders Puerto Rico fertility clinic to stop manufacturing immediately for significant violations Due to significant violations of FDA...
admin
-
November 28, 2019
0
Latest Pharma-News
IMCD again expands global network with the opening of three Pharma Technical Centres in Asia Pacific in India, Southeast Asia and China and offers...
admin
-
November 28, 2019
0
Latest Pharma-News
Zebra Medical Vision received US Food and Drug Administration (FDA) clearance for its AI-based pleural effusion diagnosis tech to identify pleural effusion
admin
-
November 28, 2019
0
Latest Pharma-News
FDA clearance for HealthLytix for breakthrough prostate imaging solution, RSI-MRI+
admin
-
November 28, 2019
0
Latest Pharma-News
USFDA Approved Silodosin Capsules, 4 mg and 8 mg for the treatment of signs and symptoms of benign prostatic hyperplasia (BPH)
admin
-
November 28, 2019
0
Latest Pharma-News
Healx commits $20M to launch Rare Treatment Accelerator programme that focus on finding new treatments for rare diseases
admin
-
November 27, 2019
0
Latest Pharma-News
KEYTRUDA, Merck’s anti-PD-1 therapy Now Approved by the National Medical Products Administration in China for First-Line Treatment of Metastatic Squamous Non-Small Cell Lung Cancer...
admin
-
November 27, 2019
0
1
...
139
140
141
...
144
Page 140 of 144
- Advertisment -
Most Read
Navigating the Job Interview: How to Answer the Question, “Why Are You Changing Jobs?”
September 16, 2023
Bayer extends Partnership with Peking University to foster Pharmaceutical Innovation in China
July 14, 2023
FDA Approves First Nonprescription Daily Oral Contraceptive
July 14, 2023
Enhertu approved in China for patients with HER2-low metastatic breast cancer
July 14, 2023